advertising
Supported by
By Reuters
STOCKHOLM – Around 3,700 more people in Sweden have been wrongly informed that they have coronavirus due to a defect in a COVID-19 control kit from China, the Public Health Agency announced on Tuesday.
The Genomics BGI kit can distinguish between very low degrees of virus and a negative result, the signature said.
“The supplier wants to adjust the functionality required for this verification to be used,” said Karin Tegmark Wisell, head of his microbiology department.
The verification kit is widely exported to other countries, he added, but may not provide additional details.
BGI Genomics, whose two subsidiaries are on an economic blacklist of U. S. corporations involved in human rights violations related to China’s recourse to Uighurs, may be contacted without delay for comment.
It won an emergency use authorization from the US government. But it’s not the first time For his coronavirus kits in March and received an emergency use list from the World Health Organization in May.
Swedish laboratories comparing tests have adjusted their methodology. The company may not say how many tests have been done with the kit, but only a minority of cases gave the impression that it was concerned when the virus is at very low levels.
Sweden said the false effects marginally affected infection statistics.
On Tuesday, the firm reported that since the first case of COVID-19 was identified, 86,891 infections had been reported in Sweden and 5,814 deaths.
Cases, ICU admissions and deaths have declined in recent weeks. The firm will contribute its strategy to some outstanding restrictions on public events, such as football matches, next Tuesday.
(Reporting through Simon Johnson)
Advertisement